Ep. 179 "Uncover What Real-World Data Means for Moderate-to-Severe Psoriasis Patients" A Sun Pharma sponsored episode.

Treatment options backed by real-world evidence means more opportunities for those living with moderate-to-severe plaque psoriasis. Join Steve Rozzo, Ph.D., Sun Pharma, and Neal Bhatia, M.D., Therapeutics Clinical Research in San Diego, CA in a Q&A discussion on real-world clinical data of ILUMYA® and what the findings mean for moderate-to-severe plaque psoriasis patients. Episode sponsored by Sun Pharma. Important safety information: https://bit.ly/2We7fIS .